https://clinicaltrials.gov/ct2/show/NCT02615691?type=Intr&cond=hemophilia&lupd_s=04%2F11%2F2019&lupd_d=14
Condition : Hemophilia A
Intervention : Biological: PEGylated Recombinant Factor VIII
Sponsor : Baxalta now part of Shire
Recruiting
BAX 855 Previously Untreated Patient (PUP)
NCT02615691
Thu, 26 Nov 2015 12:00:00 EST
Last Update Posted: 04/25/19 07:35AM